Form 4 for EW Edwards Lifesciences
Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-16 · accession 0001225208-25-005233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-05-16 | 2025-05-16 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | +5,816 | 25.7K | +29% | $0 |
| 2025-05-16 | 2025-05-16 | EW | Zovighian Bernard J | CEO, Dir | G - Gift | $0.00 | -5,816 | 81.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-16 | G | A | 5,815.55 | $0.00 | 25,662.55 | I | — | — | |
| 2 | Common | Common Stock | 2025-05-16 | G | D | 5,815.55 | $0.00 | 80,976 | D By Trust | — | — |